Free Trial

Rep. Jared Moskowitz Sells Off Shares of Cigna Group (NYSE:CI)

Cigna Group logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Representative Jared Moskowitz disclosed he sold $1,001–$15,000 of Cigna Group (NYSE:CI) stock on March 23 in his "MORGAN STANLEY ACTIVE ASSETS (5)" account and conducted a slate of other trades on March 31, including multiple purchases (e.g., Palo Alto Networks, McDonald's, Broadcom) and a $15,001–$50,000 sale of Qualcomm.
  • Cigna beat Q1 expectations (EPS $7.79 vs. $7.60; revenue $68.52B vs. $66.29B), raised FY2026 adjusted EPS guidance to $30.35, and announced a $1.56 quarterly dividend (2.2% yield), though the stock was down about 2.6% on the report.
  • Notable insider selling (Nicole S. Jones and Everett Neville) has occurred recently, while analysts maintain a consensus "Moderate Buy" with an average price target near $336.20 and institutional investors owning roughly 87% of the company.
  • Interested in Cigna Group? Here are five stocks we like better.

Representative Jared Moskowitz (Democratic-Florida) recently sold shares of Cigna Group NYSE: CI. In a filing disclosed on April 30th, the Representative disclosed that they had sold between $1,001 and $15,000 in Cigna Group stock on March 23rd. The trade occurred in the Representative's "MORGAN STANLEY ACTIVE ASSETS (5)" account.

Representative Jared Moskowitz also recently made the following trade(s):

  • Purchased $1,001 - $15,000 in shares of Palo Alto Networks NASDAQ: PANW on 3/31/2026.
  • Purchased $1,001 - $15,000 in shares of Cencora NYSE: COR on 3/31/2026.
  • Purchased $1,001 - $15,000 in shares of McDonald's NYSE: MCD on 3/31/2026.
  • Purchased $1,001 - $15,000 in shares of GE Aerospace NYSE: GE on 3/31/2026.
  • Sold $15,001 - $50,000 in shares of Qualcomm NASDAQ: QCOM on 3/31/2026.
  • Purchased $1,001 - $15,000 in shares of American Express NYSE: AXP on 3/31/2026.
  • Purchased $1,001 - $15,000 in shares of Broadcom NASDAQ: AVGO on 3/31/2026.
  • Purchased $1,001 - $15,000 in shares of Chubb NYSE: CB on 3/31/2026.
  • Sold $1,001 - $15,000 in shares of Cummins NYSE: CMI on 3/31/2026.
  • Purchased $1,001 - $15,000 in shares of General Dynamics NYSE: GD on 3/31/2026.

Cigna Group Stock Down 2.6%

NYSE CI opened at $283.14 on Friday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.74 and a current ratio of 0.73. The firm has a 50-day simple moving average of $274.34 and a 200 day simple moving average of $276.94. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00. The stock has a market cap of $74.62 billion, a PE ratio of 12.77, a PEG ratio of 1.01 and a beta of 0.30.

Cigna Group (NYSE:CI - Get Free Report) last released its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to analysts' expectations of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm's revenue was up 4.6% on a year-over-year basis. During the same quarter last year, the company earned $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, research analysts forecast that Cigna Group will post 30.35 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be paid a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Thursday, June 4th. Cigna Group's dividend payout ratio (DPR) is presently 28.13%.

Insider Activity at Cigna Group

In other news, insider Nicole S. Jones sold 2,307 shares of the firm's stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares of the company's stock, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Everett Neville sold 1,719 shares of the firm's stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the sale, the insider directly owned 5,670 shares of the company's stock, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.60% of the company's stock.

Analyst Ratings Changes

CI has been the subject of a number of analyst reports. TD Cowen raised their price target on shares of Cigna Group from $333.00 to $338.00 and gave the stock a "buy" rating in a research note on Monday, February 9th. Piper Sandler cut their price target on shares of Cigna Group from $374.00 to $370.00 and set an "overweight" rating for the company in a research note on Tuesday, March 3rd. Raymond James Financial set a $340.00 price target on shares of Cigna Group in a research note on Friday. Zacks Research upgraded shares of Cigna Group from a "strong sell" rating to a "hold" rating in a research note on Monday, January 5th. Finally, Truist Financial raised their price target on shares of Cigna Group from $320.00 to $350.00 and gave the stock a "buy" rating in a research note on Tuesday, February 17th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $336.20.

Read Our Latest Stock Analysis on CI

Key Stories Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

  • Positive Sentiment: Cigna reported Q1 results that beat revenue and most EPS expectations, driven by strong Evernorth performance; management raised 2026 adjusted EPS guidance to at least $30.35, supporting upside to valuation. Read More.
  • Positive Sentiment: Royal Bank of Canada raised its price target to $337 and kept an "outperform" rating — the move signals bull case support and implies ~19% upside from current levels. Read More.
  • Positive Sentiment: Wells Fargo nudged its target to $305 (equal‑weight), a modest endorsement that adds to recent analyst support and narrows downside concerns. Read More.
  • Neutral Sentiment: Analyst/think‑piece commentary frames the Q1 beat and Evernorth growth as a case for a higher multiple; these discussions may influence longer‑term sentiment but are not immediate catalysts. Read More.
  • Negative Sentiment: Cigna announced it will exit the Affordable Care Act (individual exchange) business in 2027, affecting roughly 369,000 members — the move reduces topline exposure and creates short‑term execution and transition risk. Read More.
  • Negative Sentiment: Pharmacy/PBM dynamics remain a watch item: rising pharmacy costs and PBM complexity were highlighted in coverage as potential margin pressure even as Evernorth grows — a risk to future earnings momentum. Read More.
  • Negative Sentiment: Some data points are mixed (small EPS/estimate variances reported by some sources) and Quiver/other trackers show notable institutional repositioning and some insider sales in recent periods — data investors watch as a potential signal of rebalancing. Read More.

Institutional Trading of Cigna Group

Several hedge funds have recently modified their holdings of CI. Wilkerson Advisory Group LLC acquired a new stake in shares of Cigna Group during the fourth quarter worth approximately $25,000. Harbor Capital Advisors Inc. increased its holdings in shares of Cigna Group by 119.5% during the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider's stock worth $26,000 after buying an additional 49 shares in the last quarter. Beacon Financial Strategies CORP acquired a new stake in shares of Cigna Group during the fourth quarter worth approximately $28,000. Cedar Mountain Advisors LLC increased its holdings in shares of Cigna Group by 161.9% during the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider's stock worth $29,000 after buying an additional 68 shares in the last quarter. Finally, Kemnay Advisory Services Inc. acquired a new stake in shares of Cigna Group during the fourth quarter worth approximately $29,000. Institutional investors and hedge funds own 86.99% of the company's stock.

About Representative Moskowitz

Jared Evan Moskowitz (Democratic Party) is a member of the U.S. House, representing Florida's 23rd Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027. Moskowitz (Democratic Party) is running for re-election to the U.S. House to represent Florida's 23rd Congressional District. He declared candidacy for the 2026 election. Jared Evan Moskowitz was born in Coral Springs, Florida. Moskowitz graduated from Marjory Stoneman Douglas High School. He earned a bachelor's degree in political science and government from George Washington University in 2003 and a law degree from Nova Southeastern University in 2007. Moskowitz's career experience includes working as the director of the Florida Division of Emergency Management and general counsel with AshBritt Inc.

Cigna Group Company Profile

(Get Free Report)

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cigna Group Right Now?

Before you consider Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.

While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines